CLASS II ONGOING Device recall · Reported 12 Aug 2026 · FDA Enforcement Report
Remisol Advance recalled by Beckman Coulter Biomedical
Beckman Coulter Biomedical is recalling Remisol Advance, distributed in Florida, Georgia, Illinois, Michigan, Pennsylvania. The recall was initiated on 29 Apr 2026 and the FDA has classified it as Class II.
Check your package
Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.
Recall details
- Recall number
- Z-2834-2026
- FDA event ID
- 98927
- Recalling firm
- Beckman Coulter Biomedical, Munchen
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- 29 Apr 2026
- FDA classified
- 31 Jul 2026
- Reported
- 12 Aug 2026
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Potency & Assay
- Device type
- Medical Software
Timeline
| 29 Apr 2026 | Recall initiated by company | |
| 31 Jul 2026 | Classified by FDA | +93 days |
| 12 Aug 2026 | Published in enforcement report | +12 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Due to software issues where does not handle combo assay results. The software may replace the final combo test result with one of the sub-results resulting in incorrect reporting of test outcomes.
Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.
Product as listed by the FDA
REMISOL Advance with Software Version 2.5 UDI-DI code: 15099590802073 The Normand Info REMISOL Advance Data Manager collects and manages data and workflow for 128 connections
Where it was distributed
U.S.: FL, GA, IL, MI, and PA O.U.S.: Belgium, France, Hungary, Poland, Taiwan (Province of China), Tunisia, United Arab Emirates, and United Kingdom of Great Britain and Northern Ireland.
Questions about this recall
Why was it recalled?
Due to software issues where does not handle combo assay results. The software may replace the final combo test result with one of the sub-results resulting in incorrect reporting of test outcomes.
Which lots are affected?
Software Version 2.5 UDI-DI code: 15099590802073
Where was it sold?
U.S.: FL, GA, IL, MI, and PA O.U.S.: Belgium, France, Hungary, Poland, Taiwan (Province of China), Tunisia, United Arab Emirates, and United Kingdom of Great Britain and Northern Ireland.
What should I do if I have it?
Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Beckman Coulter Biomedical
All 7| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS II | PE Centrifuge recalled by Beckman Coulter Biomedical | Beckman Coulter Biomedical | Foreign Material | Nationwide |
| Device | CLASS II | Power Express recalled by Beckman Coulter Biomedical | Beckman Coulter Biomedical | Foreign Material | Nationwide |
| Device | CLASS II | PE Centrifuge Temperature Controlled recalled | Beckman Coulter Biomedical | Foreign Material | Nationwide |
| Device | CLASS II | Beckman Coulter DxA Automation System, DxA recalled | Beckman Coulter Biomedical | Device Malfunction | 17 states |
| Device | CLASS II | Beckman Coulter DxA Automation System, DxA 5000 Fit recalled | Beckman Coulter Biomedical | Device Malfunction | 17 states |
Other Medical Software recalls
All 938| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS II | intelerad IntelePACS recalled by Intelerad Medical Systems | Intelerad Medical Systems | Device Malfunction | 36 states |
| Device | CLASS I | Prosthesis, mitral valve, percutaneously delivered Component: No recalled | Edwards Lifesciences | Device Malfunction | 24 states |
| Device | CLASS II | Nalu TD2 Therapy Disc with firmware recalled by Boston Scientific | Boston Scientific Neuromodulation | Other | Nationwide |
| Device | CLASS II | Metatarsophalangeal (MTP) Implant is a sterile recalled by restor3d | restor3d | Sterility | Nationwide |
| Device | CLASS II | Ion Torrent Genexus Dx recalled by Life Technologies Holdings Pte | Life Technologies Holdings Pte | Device Malfunction | Nationwide |